Rogmans, C.; Feuerborn, J.; Treeck, L.; Tribian, N.; Flörkemeier, I.; Arnold, N.; Weimer, J.P.; Maass, N.; Jansen, P.; Lieb, W.;
et al. Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages. Cancers 2022, 14, 5867.
https://doi.org/10.3390/cancers14235867
AMA Style
Rogmans C, Feuerborn J, Treeck L, Tribian N, Flörkemeier I, Arnold N, Weimer JP, Maass N, Jansen P, Lieb W,
et al. Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages. Cancers. 2022; 14(23):5867.
https://doi.org/10.3390/cancers14235867
Chicago/Turabian Style
Rogmans, Christoph, Julia Feuerborn, Leonie Treeck, Nils Tribian, Inken Flörkemeier, Norbert Arnold, Jörg Paul Weimer, Nicolai Maass, Peer Jansen, Wolfgang Lieb,
and et al. 2022. "Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages" Cancers 14, no. 23: 5867.
https://doi.org/10.3390/cancers14235867
APA Style
Rogmans, C., Feuerborn, J., Treeck, L., Tribian, N., Flörkemeier, I., Arnold, N., Weimer, J. P., Maass, N., Jansen, P., Lieb, W., Dempfle, A., Bauerschlag, D. O., & Hedemann, N.
(2022). Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages. Cancers, 14(23), 5867.
https://doi.org/10.3390/cancers14235867